| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |